摘要
目的分析本院临床分离鲍曼不动杆菌的耐药性,为临床提供控制和治疗该菌感染的可靠依据。方法细菌培养分离按照《全国临床检验操作规程》进行。采用法国生物梅里埃公司全自动微生物鉴定系统进行菌种鉴定及配套药盒做药敏,药敏试验结果按照CLSI标准判定,采用WHONT5.4软件进行数据分析。结果分离的鲍曼不动杆菌主要分布在ICU、呼吸科感染患者,有较高耐药率,阿米卡星耐药率最低为34.4%,其余的耐药率均在50%以上。结论鲍曼不动杆菌耐药率较高,应引起临床高度重视。
Objective To offer reliable evidence to control and treat the infection of baumanii, we have analyzed the anti- microbial resistance of baumanii strains form patients in our hospital. Methods According to the national clinical inspection oper- ation specifications to separation bacteria and bacterial cultures. Use V1TEK of france＇s biological merry company to strains identi- fied and drug susceptibility test with it＇ s pillbox. The results standard judgement according to the CLSI. Use tile WHONT5.4 soft- ware to analyzes the data. Results The acinetobacter baumannii in our hospital mainly distribute in ICU and department of respir atory medicine, Drug Resistance Rate is higher, amikacin has minimum resistance is 34. 4%, The rest of the resistance are more than 50%. Conclusion Acinetobacter baumannii has higher drug resistance rate, which should be more high attention to clinical doctors.
出处
《四川医学》
CAS
2012年第12期2213-2214,共2页
Sichuan Medical Journal
关键词
鲍曼不动杆菌
感染
耐药性
aeinetobacter baumannii
infection
antimicrobial resistance
